Next Capital Management LLC Cyto Dyn Inc. Transaction History
Next Capital Management LLC
- $242 Million
- Q3 2024
A detailed history of Next Capital Management LLC transactions in Cyto Dyn Inc. stock. As of the latest transaction made, Next Capital Management LLC holds 32,500 shares of CYDY stock, worth $3,900. This represents 0.0% of its overall portfolio holdings.
Number of Shares
32,500Holding current value
$3,900% of portfolio
0.0%Shares
8 transactions
Others Institutions Holding CYDY
# of Institutions
9Shares Held
406KCall Options Held
0Put Options Held
0-
Eagle Bay Advisors LLC New York, NY162KShares$19,4530.01% of portfolio
-
Mai Capital Management47.5KShares$5,6970.0% of portfolio
-
Diversified Trust CO45.8KShares$5,4940.0% of portfolio
-
Williams Jones Wealth Management, Llc. New York, NY45KShares$5,4000.0% of portfolio
-
Rfp Financial Group LLC Atlanta, GA41.5KShares$4,9740.0% of portfolio
About CytoDyn Inc.
- Ticker CYDY
- Exchange OTC
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 813,040,000
- Market Cap $97.6M
- Description
- CytoDyn Inc. operates as a clinical-stage biotechnology company. The company focuses on developing treatments for multiple therapeutic indications based on leronlimab, a novel humanized monoclonal antibody targeting the CCR5 receptor in the areas of human immunodeficiency virus (HIV), non-alcoholic steatohepatitis (NASH), oncology, and such as c...